MHRA
- Status: likely_approved
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS) regulatory status in United Kingdom.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA has authorised it; MHRA has authorised it; MHRA has authorised it.
Marketing authorisation holder not available in our data.